|
Market Closed -
Other stock markets
|
After market 06:24:27 am | |||
| 176.19 USD | +0.01% |
|
178.99 | +1.59% |
| 05/12 | Wall Street's gravity-defying rally awaits non-farm payrolls verdict |  |
| 05/12 | Analyst recommendations: Applovin, Chewy, Netflix, Deliveroo, Diageo... | |
| Capitalization | 31TCr 29TCr 27TCr 24TCr 44TCr 26,36800Cr 49TCr 3,39800Cr 1,25600Cr 10,83400Cr 1,17000Cr 1,14400Cr 46,67900Cr | P/E ratio 2024 * |
37.1x | P/E ratio 2025 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise value | 37TCr 35TCr 32TCr 29TCr 52TCr 31,26500Cr 58TCr 4,03000Cr 1,49000Cr 12,84600Cr 1,38700Cr 1,35600Cr 55,34800Cr | EV / Sales 2024 * |
6.59x | EV / Sales 2025 * | 6.1x |
| Free-Float |
96.39% | Yield 2024 * |
3.54% | Yield 2025 * | 3.71% |
More valuation ratios
* Estimated data
More news
Last Transcript: AbbVie Inc.
More recommendations
More press releases
More news
| 1 day | +1.59% | ||
| 1 week | -3.68% | ||
| Current month | -3.68% | ||
| 1 month | -12.43% | ||
| 3 months | -8.90% | ||
| 6 months | +4.52% | ||
| Current year | +13.69% |
1 week
173.53
183.51
1 month
163.81201.89
Current year
153.58207.32
1 year
148.00207.32
3 years
120.75207.32
5 years
62.55207.32
10 years
45.45207.32
| Director | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 23/06/2022 |
Roopal Thakkar
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2003 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Gonzalez
CHM | Chairman | 70 | 01/01/2013 |
Roxanne Austin
BRD | Director/Board Member | 63 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 72 | 01/01/2013 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.12% | 7 M€ | +21.18% | - | |
| 6.85% | 20 M€ | +16.75% | - | |
| 6.26% | 13 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.01% | -3.68% | +20.36% | +45.19% | 31TCr | ||
| +0.13% | +3.94% | +40.30% | +235.61% | 74TCr | ||
| +1.88% | +3.72% | +15.77% | +121.70% | 49TCr | ||
| -0.14% | -3.68% | -4.67% | -8.37% | 36TCr | ||
| -0.44% | +1.43% | -2.40% | +40.41% | 26TCr | ||
| +0.27% | +0.59% | +2.82% | -30.08% | 24TCr | ||
| +0.34% | +0.40% | +5.17% | +27.39% | 21TCr | ||
| -0.63% | -3.71% | +5.80% | +20.34% | 20TCr | ||
| -0.64% | -3.64% | +1.20% | +30.55% | 15TCr | ||
| +0.12% | -1.83% | -10.63% | -50.02% | 15TCr | ||
| Average | +0.21% | -0.49% | +7.37% | +43.27% | 31.12TCr | |
| Weighted average by Cap. | +0.38% | +0.50% | +13.94% | +82.59% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 5.6TCr 5.3TCr 4.92TCr 4.4TCr 7.92TCr 4,74600Cr 8.77TCr 61TCr 23TCr 1,95000Cr 21TCr 21TCr 8,40100Cr | 5.91TCr 5.59TCr 5.18TCr 4.64TCr 8.36TCr 5,00500Cr 9.25TCr 65TCr 24TCr 2,05600Cr 22TCr 22TCr 8,86100Cr |
| Net income | 825.11Cr 780.8Cr 723.81Cr 647.32Cr 1.17TCr 70TCr 1.29TCr 9.01TCr 3.33TCr 29TCr 3.1TCr 3.03TCr 1,23700Cr | 1.2TCr 1.14TCr 1.05TCr 942.85Cr 1.7TCr 1,01800Cr 1.88TCr 13TCr 4.85TCr 42TCr 4.51TCr 4.41TCr 1,80200Cr |
| Net Debt | 5.78TCr 5.47TCr 5.07TCr 4.54TCr 8.18TCr 4,89700Cr 9.05TCr 63TCr 23TCr 2,01200Cr 22TCr 21TCr 8,66900Cr | 4.89TCr 4.63TCr 4.29TCr 3.84TCr 6.92TCr 4,14300Cr 7.66TCr 53TCr 20TCr 1,70200Cr 18TCr 18TCr 7,33500Cr |
More financial data
* Estimated data
Employees
50,000
Sector
Pharmaceuticals
Calendar
15/01/2025
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/24/06 | 176.19 $ | +0.01% | 4,839,640 |
| 05/24/05 | 176.17 $ | -0.16% | 5,444,240 |
| 04/24/04 | 176.46 $ | -2.78% | 6,125,479 |
| 03/24/03 | 181.50 $ | -0.15% | 4,107,553 |
| 02/24/02 | 181.77 $ | -0.63% | 3,936,877 |
Delayed Quote Nyse, December 07, 2024 at 02:30 am IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
176.19USD
Average target price
202.88USD
Spread / Average Target
+15.15%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition